Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Open ; 14(5): e081041, 2024 May 28.
Article in English | MEDLINE | ID: mdl-38806423

ABSTRACT

INTRODUCTION: Neuropsychiatric symptoms (NPS) are common non-motor symptoms among patients with Parkinson's disease (PD) and significantly impact their overall quality of life detrimentally. Several studies have reported the clinical effect of acupuncture therapy in treating NPS in PD. Therefore, the objective of this systematic review is to evaluate the potential inclusion of acupuncture therapy as an integral component of complementary treatment for PD with NPS. METHODS AND ANALYSIS: From their inception until 1 December 2023, we will search eight databases, including PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, China Science Periodical Database, Chinese Citation Database and China Biology Medicine disc for randomised controlled trials examining the effectiveness of acupuncture for PD with NPS. Literature screening and data extraction will be carried out independently by the authors. RevMan V.5.3 software will be used for meta-analysis, while the Cochrane risk-of-bias tool will assess the potential for bias. ETHICS AND DISSEMINATION: This systematic review protocol does not require ethical approval because it does not include private information or data of participants. This article will be published in a peer-reviewed journal. PROSPERO REGISTRATION NUMBER: CRD42022324494.


Subject(s)
Acupuncture Therapy , Meta-Analysis as Topic , Parkinson Disease , Systematic Reviews as Topic , Humans , Acupuncture Therapy/methods , Parkinson Disease/therapy , Parkinson Disease/complications , Research Design , Quality of Life , Randomized Controlled Trials as Topic , Treatment Outcome
2.
Chem Commun (Camb) ; 59(23): 3427-3430, 2023 Mar 16.
Article in English | MEDLINE | ID: mdl-36857619

ABSTRACT

The oxygen evolution reaction (OER) is a vital half-reaction in several electrochemical energy conversion devices. Herein, we report a hierarchical NiMoO4/NiFe LDH pre-catalyst that enables complete reconstruction and fine structural inheritance, while exhibiting a low overpotential of 188 mV at 10 mA cm-2 in 1.0 M KOH.

3.
ACS Appl Mater Interfaces ; 15(1): 1317-1325, 2023 Jan 11.
Article in English | MEDLINE | ID: mdl-36542820

ABSTRACT

Catalytic hydrogenation plays an important role in the industrial production of fine chemicals. Herein, we report a Co-doped MoS2 and CoS2 composite with a coupling interface and successfully apply it for the chemoselective hydrogenation of p-chloronitrobenzene to p-chloroaniline. The target catalyst 0.5CoMoS has ∼100% conversion and ∼100% selectivity. Experiments and theoretical calculations reveal that CoS2 is more favorable for adsorbing and activating H2 and provides active hydrogen (Ha) to Co-doped MoS2 by the coupling interface. By matching the production and consumption rates of Ha, the maximization of the reaction yield was achieved. This work may promote the study of MoS2-based catalysts for chemoselective hydrogenation.

SELECTION OF CITATIONS
SEARCH DETAIL
...